- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 239/12 - Nitrogen atoms not forming part of a nitro radical
Patent holdings for IPC class C07D 239/12
Total number of patents in this class: 32
10-year publication summary
|
0
|
0
|
2
|
0
|
2
|
2
|
2
|
0
|
2
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Centre National de La Recherche Scientifique | 10531 |
2 |
| Abivax | 122 |
2 |
| Institut Curie | 591 |
2 |
| Universite de Montpellier | 999 |
2 |
| UPL Limited | 591 |
2 |
| Sanofi | 4093 |
2 |
| BASF SE | 20991 |
1 |
| LG Chem, Ltd. | 17656 |
1 |
| The Regents of the University of California | 20087 |
1 |
| Merck Sharp & Dohme Corp. | 2191 |
1 |
| AstraZeneca AB | 2895 |
1 |
| AstraZeneca UK Limited | 628 |
1 |
| Vertex Pharmaceuticals Incorporated | 1627 |
1 |
| Acetylon Pharmaceuticals, Inc. | 69 |
1 |
| Aurobindo Pharma Ltd | 154 |
1 |
| BioCryst Pharmaceuticals, Inc. | 176 |
1 |
| Cystic Fibrosis Foundation Therapeutics, Inc. | 8 |
1 |
| Korea Research Institute of Chemical Technology | 1401 |
1 |
| Mixture Sciences, Inc. | 1 |
1 |
| MSN Laboratories Limited | 56 |
1 |
| Other owners | 6 |